BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31013740)

  • 1. Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents.
    Whitaker RH; Placzek WJ
    Cells; 2019 Apr; 8(4):. PubMed ID: 31013740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-APCAs, the Novel Microtubule Targeting Agents Active Against Distinct Cancer Cell Lines.
    Boichuk S; Galembikova A; Bikinieva F; Dunaev P; Aukhadieva A; Syuzov K; Zykova S; Igidov N; Ksenofontov A; Bocharov P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33503939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitosis and apoptosis: how is the balance set?
    Topham CH; Taylor SS
    Curr Opin Cell Biol; 2013 Dec; 25(6):780-5. PubMed ID: 23890995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy.
    Barillé-Nion S; Bah N; Véquaud E; Juin P
    Anticancer Res; 2012 Oct; 32(10):4225-33. PubMed ID: 23060542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubules, microtubule-interfering agents and apoptosis.
    Mollinedo F; Gajate C
    Apoptosis; 2003 Oct; 8(5):413-50. PubMed ID: 12975575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubules in apoptosis induction: are they necessary?
    Estève MA; Carré M; Braguer D
    Curr Cancer Drug Targets; 2007 Dec; 7(8):713-29. PubMed ID: 18220532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death.
    Huang S; Tang R; Poon RY
    Oncotarget; 2016 Jun; 7(25):38718-38730. PubMed ID: 27231850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
    Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
    Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance.
    Ogden A; Rida PC; Reid MD; Kucuk O; Aneja R
    Expert Rev Anticancer Ther; 2015 Mar; 15(3):277-81. PubMed ID: 25695344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
    Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
    Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
    Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
    Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule-targeted anticancer agents and apoptosis.
    Bhalla KN
    Oncogene; 2003 Dec; 22(56):9075-86. PubMed ID: 14663486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest.
    Haschka MD; Soratroi C; Kirschnek S; Häcker G; Hilbe R; Geley S; Villunger A; Fava LL
    Nat Commun; 2015 Apr; 6():6891. PubMed ID: 25922916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY; Lerner A
    Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-related BCL2-family members: Key players in chemotherapy.
    Kontos CK; Christodoulou MI; Scorilas A
    Anticancer Agents Med Chem; 2014 Mar; 14(3):353-74. PubMed ID: 23848200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.
    Hasanpourghadi M; Karthikeyan C; Pandurangan AK; Looi CY; Trivedi P; Kobayashi K; Tanaka K; Wong WF; Mustafa MR
    J Exp Clin Cancer Res; 2016 Mar; 35():58. PubMed ID: 27030360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
    Mohan R; Panda D
    Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance.
    Manzoor S; Bilal A; Khan S; Ullah R; Iftikhar S; Emwas AH; Alazmi M; Gao X; Jawaid A; Saleem RSZ; Faisal A
    Sci Rep; 2018 Feb; 8(1):3305. PubMed ID: 29459693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
    Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
    Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.